AAAAAA

   
Results: 1-15 |
Results: 15
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors
Authors: Santagostino, E Morfini, M Rocino, A Baudo, F Scaraggi, FA Gringeri, A
Citation: E. Santagostino et al., Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors, THROMB HAEM, 86(4), 2001, pp. 954-958
TT virus contaminates first-generation recombinant factor VIII concentrates
Authors: Azzi, A De Santis, R Morfini, M Zakrzewska, K Musso, R Santagostino, E Castaman, G
Citation: A. Azzi et al., TT virus contaminates first-generation recombinant factor VIII concentrates, BLOOD, 98(8), 2001, pp. 2571-2573
Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs
Authors: Asselta, R Duga, S Spena, S Santagostino, E Peyvandi, F Piseddu, G Targhetta, R Malcovati, M Mannucci, PM Tenchini, ML
Citation: R. Asselta et al., Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs, BLOOD, 98(13), 2001, pp. 3685-3692
Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy
Authors: Santagostino, E Mannucci, PM Bonomi, AB
Citation: E. Santagostino et al., Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy, HAEMOPHILIA, 6(1), 2000, pp. 1-10
Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection
Authors: Brambilla, A Villa, C Rizzardi, G Veglia, F Ghezzi, S Lazzarin, A Cusini, M Muratori, S Santagostino, E Gringeri, A Louie, LG Sheppard, HW Poli, G Michael, NL Pantaleo, G Vicenzi, E
Citation: A. Brambilla et al., Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection, J INFEC DIS, 182(1), 2000, pp. 311-315
A novel two base pair deletion in the factor V gene associated with severefactor V deficiency
Authors: Montefusco, MC Duga, S Asselta, R Santagostino, E Mancuso, G Malcovati, M Mannucci, PM Tenchini, ML
Citation: Mc. Montefusco et al., A novel two base pair deletion in the factor V gene associated with severefactor V deficiency, BR J HAEM, 111(4), 2000, pp. 1240-1246
Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation
Authors: Asselta, R Duga, S Simonic, T Malcovati, M Santagostino, E Giangrande, PLF Mannucci, PM Tenchini, ML
Citation: R. Asselta et al., Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation, BLOOD, 96(7), 2000, pp. 2496-2500
Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion
Authors: Duga, S Asselta, R Santagostino, E Zeinali, S Simonic, T Malcovati, M Mannucci, PM Tenchini, ML
Citation: S. Duga et al., Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion, BLOOD, 95(4), 2000, pp. 1336-1341
Active anti-interferon-alpha immunization: A European-Israeli, randomized,double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study)
Authors: Gringeri, A Musicco, M Hermans, P Bentwich, Z Cusini, M Bergamasco, A Santagostino, E Burny, A Bizzini, B Zagury, D
Citation: A. Gringeri et al., Active anti-interferon-alpha immunization: A European-Israeli, randomized,double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study), J ACQ IMM D, 20(4), 1999, pp. 358-370
Tat toxoid as a component of a preventive vaccine in seronegative subjects
Authors: Gringeri, A Santagostino, E Muca-Perja, M Le Buanec, H Bizzini, B Lachgar, A Zagury, JF Rappaport, J Burny, A Gallo, RC Zagury, D
Citation: A. Gringeri et al., Tat toxoid as a component of a preventive vaccine in seronegative subjects, J ACQ IMM D, 20(4), 1999, pp. 371-375
Frequency of a mutated CCR-5 allele (Delta 32) among Italian healthy donors and individuals at risk of parenteral HIV infection
Authors: Zamarchi, R Indraccolo, S Minuzzo, S Coppola, V Gringeri, A Santagostino, E Vicenzi, E De Silvestro, G Biagiotti, R Baldassarre, C Chieco-Bianchi, L Amadori, A
Citation: R. Zamarchi et al., Frequency of a mutated CCR-5 allele (Delta 32) among Italian healthy donors and individuals at risk of parenteral HIV infection, AIDS RES H, 15(4), 1999, pp. 337-344
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy
Authors: Zagury, D Lecoq, H Gervi, I Le Buanec, H Zagury, JF Bizzini, B Burny, A Hermans, P Perja, M Santagostino, E Gringeri, A
Citation: D. Zagury et al., Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy, BIOMED PHAR, 53(2), 1999, pp. 90-92
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection
Authors: Brambilla, A Turchetto, L Gatti, A Bovolenta, C Veglia, F Santagostino, E Gringeri, A Clementi, M Poli, G Bagnarelli, P Vicenzi, E
Citation: A. Brambilla et al., Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection, VIROLOGY, 259(2), 1999, pp. 349-368
Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention
Authors: Santagostino, E Gringeri, A Mannucci, PM
Citation: E. Santagostino et al., Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention, BR J HAEM, 104(1), 1999, pp. 22-26
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid
Authors: Le Buanec, H Lachgar, A Bizzini, B Zagury, JF Rappaport, J Santagostino, E Muca-Perja, M Gringeri, A
Citation: H. Le Buanec et al., A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid, BIOMED PHAR, 52(10), 1998, pp. 431-435
Risultati: 1-15 |